spacer
home > ict > summer 2018 > navigating global complexities
PUBLICATIONS
International Clinical Trials

Navigating Global Complexities

Insurance is a small part of the global clinical trial process, but it can have a huge impact on the contract or clinical research company’s efforts geared towards ensuring trials proceed smoothly.

Making sure a clinical trial’s insurance policy stands up to the scrutiny of the ethics committee in each territory is essential. Inappropriate insurance documentation presented to the ethics committee meeting could delay the onset of the trial until at least their next meeting, reducing the patent exclusivity period, potentially costing millions of pounds and negatively affecting important business relationships.

Having a sound understanding of the legislation and regulations governing clinical trials in the territory where the company is testing is the best starting point.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kathryn Moon is ACII qualified and has worked in the insurance industry for over 20 years in a variety of roles including Account Broker, Project Manager, Development Manager, and Account Executive. She is currently Managing Director of the Coventry office of Gallagher – the global insurance broker, risk management services, and consulting firm – and an integral part of its UK life sciences specialism. Gallagher are also members of OBN.
spacer
Kathryn Moon
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Philadelphia, USA – October 15, 2018. Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced the completion of a dedicated Returns Management facility at its Clinical Services Center of Excellence at Bridgend, UK. PCI provides a full service Returns Management service for clients, providing visibility and accountability in returning investigational drug product from investigational sites at the conclusion of a clinical study. Returning and reconciling Investigational Medicinal Product (IMP) on completion of a study is a critical part of a Clinical trial and can require complex reverse logistics. Trial outcomes can be impacted if Returns are not processed efficiently and precisely.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

Pre-Filled Syringes & Injectable Drug Devices Europe

16-17 January 2019, Copthorne Tara Hotel, London

SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement